Bayer partners with CureVac on coronavirus vaccine development
Dive Brief: CureVac is linking up with giant German drugmaker Bayer for help in developing and eventually supplying its experimental coronavirus vaccine, the companies announced Thursday. Under the deal, Bayer will support CureVac's efforts in a number of countries, particularly within the European Union. Bayer has options to hold regulatory approval rights in markets outside Europe. Working together, the companies said they can supply several hundreds of millions of doses around the world should the vaccine win regulatory approvals. CureVac had already been expanding its manufacturing networ...